Because GLP-1 medications lead to weight loss that includes fat and muscle, the skin will lose some of its collagen content, explains board-certified dermatologist Raja Sivamani, MD, MS, AP
GLP-1 Therapies Transforming Obesity Treatment in India Published on 28 Feb, 2025 India's growing obesity burden has accelerated interest in effective treatment options
This distinction matters enormously and it is often completely ignored in how GLP-1 therapy is monitored
Monitoring recommendations Researchers using cagrilintide should consider regular monitoring including: Blood work every 3 to 6 months including metabolic panel, lipid panel, liver function, and pancreatic enzymes Thyroid function tests at baseline and periodically Body composition assessment to track lean mass versus fat mass changes Heart rate monitoring particularly during titration Nutritional status markers including vitamin B12, iron, and vitamin D The peptide research and studies section provides broader context for evaluating emerging safety data as it becomes available